Symbio Pharmaceuticals Ltd (4582) Stock Price & News

4582:TYO

Symbio Pharmaceuticals Ltd

¥56.00

0.00%

(0.00) 1D

Oct 1, 11:09:28 AM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4582...

Open

¥57

High

¥57

Low

¥55

Mkt. cap

4.49B

Avg. vol.

823.86K

Volume

153.40K

52-wk high

¥229

52-wk low

¥53

EPS

-¥98

Shares outstanding

82.40M

No. of employees

Open

¥57

High

¥57

Low

¥55

Mkt. cap

4.49B

Avg. vol.

823.86K

Volume

153.40K

52-wk high

¥229

52-wk low

¥53

EPS

-¥98

Shares outstanding

82.40M

No. of employees

Related stocks

D.Western Therapeutics Institute Inc

¥75.00

-2.60%

4564

OncoTherapy Science, Inc.

¥20.00

-4.76%

News stories

From web sources and news partners

WBOC TV

2 hours ago

Chilwa Announces Nasdaq Listing and Pricing of US$3.5 Million Offering

Seeking Alpha

7 minutes ago

Lower-Than-Expected PCE Data Failed To Help Markets (SP500)

Barchart.com

30 minutes ago

What You Need To Know Ahead of Nasdaq's Earnings Release

WSJ

4 hours ago

A Tech-Fueled Stock Market Powers Through, but Limps Into the Fourth Quarter

About Symbio Pharmaceuticals Ltd

CEO-

Employees91

FoundedMar 25, 2005

HeadquartersMinato City, Tokyo, Japan

SectorPharmaceutical industry

Websitesymbiopharma.com

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	324.17M	336.19M	233.46M	235.54M
Cost of goods sold	122.29M	84.64M	60.63M	71.37M
Cost of revenue	122.29M	84.64M	60.63M	71.37M
Research and development expenses	868.70M	846.40M	1.99B	-1.99B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	518.54M	506.73M	522.11M	3.45B
Operating expense	1.39B	1.35B	2.51B	1.46B
Total operating expenses	1.51B	1.44B	2.57B	1.53B
Operating income	-1.19B	-1.10B	-2.34B	-1.29B
Other non operating income	-1.57M	14.49M	-6.26M	85.26M
EBT including unusual items	-1.20B	-1.19B	-2.39B	-1.21B
EBT excluding unusual items	-1.20B	-1.09B	-2.39B	-1.22B
Income tax expense	-3.66M	18.88M	13.97M	4.03M
Effective tax rate	0.30%	-1.58%	-0.58%	-0.33%
Other operating expenses	-	-	-	-
Net income	-1.20B	-1.21B	-2.40B	-1.22B
Net profit margin	-369.09%	-360.02%	-1,028.60%	-516.94%
Earnings per share	-	-	-	-
Interest and investment income	1.73M	653.00K	2.25M	-
Interest expense	-29.04M	-11.12M	-16.63M	-16.62M
Net interest expenses	-27.31M	-10.47M	-14.38M	-16.62M
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything